Oxypharm NOCOSPRAY - Page 32

32
DA
5.3 Visualisering af historik indholdet .................................................................................................. 49
5.3.1 Beskrivelse af Skærm ...................................................................................................................49
5.3.2 Ændring af generelle indsllinger .............................................................................................50
5.3.3 Eksport af historik i PDF format ................................................................................................51
5.3.4 Afslue USB mode .......................................................................................................................52
6. BILAG 52
6.1 Sended og -forbrug .......................................................................................................................... 52
6.2 Vedligeholdelse ................................................................................................................................... 53
6.3 Tekniske karakteriska .................................................................................................................... 53
6.4 EMC-overensstemmelses tabel ....................................................................................................... 54
7. EMC-overensstemmelses tabel 54
7.1 Kabellængde ........................................................................................................................................ 54
7.2 Anbefalet minimumsafstand ............................................................................................................ 54
7.3 Elektromagnesk emission .............................................................................................................. 54
7.4 Elektromagnesk og magnesk emission .................................................................................... 55
7.5 Elektromagnesk emission, RF ....................................................................................................... 56
8. GENANVENDELSE 57